Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors.
about
Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosisTherapeutic potential of statins and the induction of heme oxygenase-1 in preeclampsiaRedox regulation of stem/progenitor cells and bone marrow nicheIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesSafety and efficacy of bone marrow-derived autologous CD133+ stem cell therapy.Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome: implications for increased cardiovascular risk.Improvement of cardiac function in mouse myocardial infarction after transplantation of epigenetically-modified bone marrow progenitor cells.Medical treatment of diabetic retinopathy with somatostatin analogues.High glucose impairs the proliferation and increases the apoptosis of endothelial progenitor cells by suppression of Akt.Augmentation of neovascularization in murine hindlimb ischemia by combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells transplantation.Cardiomyocyte-specific Estrogen Receptor Alpha Increases Angiogenesis, Lymphangiogenesis and Reduces Fibrosis in the Female Mouse Heart Post-Myocardial Infarction.Simvastatin decreases endothelial progenitor cell apoptosis in the kidney of hypertensive hypercholesterolemic pigsOver-expression of PDGFR-β promotes PDGF-induced proliferation, migration, and angiogenesis of EPCs through PI3K/Akt signaling pathwayThe GM-CSF/IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling.Endothelial progenitor cells as factors in neovascularization and endothelial repairCirculating endothelial progenitor cell and platelet microparticle impact on platelet activation in hypertension associated with hypercholesterolemia.Isolation and characterization of endothelial progenitor cells from Rhesus monkeys.Catalpol protects mice against renal ischemia/reperfusion injury via suppressing PI3K/Akt-eNOS signaling and inflammation.Effects of olmesartan on endothelial progenitor cell mobilization and function in carotid atherosclerosis.In stent restenosis: bane of the stent era.Enhanced angiogenic and cardiomyocyte differentiation capacity of epigenetically reprogrammed mouse and human endothelial progenitor cells augments their efficacy for ischemic myocardial repair.New vectors and strategies for cardiovascular gene therapy.Cell-free embryonic stem cell extract-mediated derivation of multipotent stem cells from NIH3T3 fibroblasts for functional and anatomical ischemic tissue repair.The role of endothelial progenitor cells in ischemic cerebral and heart diseases.Pathophysiology of coronary artery in-stent restenosis.Mesenchymal stem cells as a treatment for peripheral arterial disease: current status and potential impact of type II diabetes on their therapeutic efficacy.Oxidative stress impairs endothelial progenitor cell function.Platelets modulate atherogenesis and progression of atherosclerotic plaques via interaction with progenitor and dendritic cells.Impact of adherence to statins on chronic heart failure in primary prevention.Atherosclerosis as a disease of failed endogenous repairAMP-activated protein kinase promotes the differentiation of endothelial progenitor cells.Chronic inhibition of endoplasmic reticulum stress and inflammation prevents ischaemia-induced vascular pathology in type II diabetic mice.Transplantation of endothelial progenitor cells as therapeutics for cardiovascular diseases.Heme oxygenase-1 is required for angiogenic function of bone marrow-derived progenitor cells: role in therapeutic revascularization.Imbalance between endothelial damage and repair: a gateway to cardiovascular disease in systemic lupus erythematosus.Autologous cell therapy for cardiac repair.Resveratrol in cardiovascular disease: what is known from current research?Mobilization of stem and progenitor cells in cardiovascular diseases.Serum levels of advanced glycation end products (AGEs) are inversely associated with the number and migratory activity of circulating endothelial progenitor cells in apparently healthy subjects.The cornucopia of "pleiotropic" actions of statins: myogenesis as a new mechanism for statin-induced benefits?
P2860
Q21245469-337054E9-A710-438F-B3C7-E5DEC9EECD08Q26849333-EE577DF3-7DA7-43A0-82EB-63CC3D769055Q26851313-1D6BF085-4D3C-4C01-8E50-E1848A0C29B3Q28388335-23EEB43A-E41C-47B4-9A0D-C5380669B3B6Q30428262-F2C69E31-F5F9-4CB9-8344-F9C9A50E6985Q30495462-DDD45DC1-9D1C-457F-A717-130C07B72937Q31028296-A6F1DCD4-7D1F-4485-88FD-CFA1AF278DDFQ33265910-71F45BF8-01C6-4A2F-B84B-AFCDB1283900Q33585842-C7D372F6-567D-4840-A822-F935B77F38C4Q33694021-45658023-A9C4-4B93-AD3C-D968BEA852DCQ33803183-E3C60369-89CF-4B4B-88C6-1637E1E3DD1DQ33835733-DB1656E1-F85C-4AA3-BB12-A191DFA0C8AEQ34166170-B0BFB6CE-FD7D-4C25-ABCF-8B8CA05D4AF7Q34304678-B7122D50-7A94-4CB6-996E-B36A1B0D37EFQ34444790-FB329DF8-18D1-418B-B4BC-9AB13BDE6BCCQ34570853-090212F8-3325-4159-8795-5C1D9EF5E588Q35321370-4B7FFBD1-AC52-45BC-AFAE-3D49ABF2142BQ35479838-E2EB1486-7A0D-43D3-B057-35F047A7C987Q35575710-0EC34D3E-CFC1-49F7-861D-8C49F9B30134Q35769824-4B81CDB1-571D-407B-A270-49FE9F7EFF71Q36121810-F3F8CCCE-46B3-4427-9596-C7E81D87D120Q36174173-5CA39D2B-512A-4674-9A31-C05920C0ACDEQ36731424-E2E541B6-E917-4CC9-ABC6-8666B453B25FQ36822315-EE655F7F-01C3-496A-9F8C-2671256B164FQ36851067-892E529A-7CFC-4F7C-848B-C85664381FD4Q36930468-3C6B85B0-E712-4788-A047-E59A2A972F72Q36953696-8B278FE2-78E5-46D5-A540-2F92523C8434Q37035357-26E3B585-BA1B-48E7-922F-B6D665FF98CDQ37142460-AA8577DD-D842-4E1A-B225-35E1DF1F66E4Q37152177-0C7DC7AB-676B-4F94-8E94-12CE12AA4F46Q37332718-FFE93F1F-899D-4760-ADBA-924F12488A42Q37560294-28A26795-AC48-4C46-9290-58660C3B4D06Q37570669-5C41CED8-0201-4D4D-B9FE-AD3E8545557CQ37653826-65E2CE5D-020A-4D46-A0DB-DD695C5DE446Q37699812-47AC2D58-6D6F-46EC-A6DD-E645E696B392Q37837891-D2110B9A-9673-4BF3-8C9D-44D368150770Q37891880-F57173CC-DCEA-4FD9-A500-FE72163F2559Q37905521-42E3909D-3433-43C7-A5E0-0BDE6CDDD65AQ39711731-F7412F50-3450-4A35-B71C-20927DE7DDCEQ42559372-21FBAFDE-6884-4CF7-AE3D-9D325C10229D
P2860
Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Risk factors for coronary arte ...... HMG-CoA reductase inhibitors.
@ast
Risk factors for coronary arte ...... HMG-CoA reductase inhibitors.
@en
type
label
Risk factors for coronary arte ...... HMG-CoA reductase inhibitors.
@ast
Risk factors for coronary arte ...... HMG-CoA reductase inhibitors.
@en
prefLabel
Risk factors for coronary arte ...... HMG-CoA reductase inhibitors.
@ast
Risk factors for coronary arte ...... HMG-CoA reductase inhibitors.
@en
P1433
P1476
Risk factors for coronary arte ...... HMG-CoA reductase inhibitors.
@en
P304
P356
10.1111/J.1523-1755.2005.00261.X
P407
P577
2005-05-01T00:00:00Z
P5875
P6179
1023859436